Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3729704015 | Beta-galactosidase only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3729705019 | Product containing only beta-galactosidase (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2850991000001117 | Tilactase (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2851001000001118 | Tilactase | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tilactase | Is a | Product containing beta-galactosidase (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Tilactase | Has active ingredient | Beta-galactosidase | true | Inferred relationship | Existential restriction modifier | 1 | |
| Tilactase | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Tilactase | Plays role | Digestant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Tilactase | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tilactase 200mg tablets | Is a | True | Tilactase | Inferred relationship | Existential restriction modifier | |
| Tilactase 50,000units/g oral drops | Is a | True | Tilactase | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR